Corneal neovascularization

Riboflavin (B ) FADIHj) Dehydrogenases Many Corneal neovascularization Cheilosis or stomatitis (cracking or scaling of lip borders and corners of the mouth) Magenta-colored tongue... 

Sikder, S., Herretes, S.P., Gehlbach, P, Gurewitsch, E., Behrens, A. Topical human amniotic inhibition of induced corneal neovascularization. ARVO Abstracts No 1650 Fort Lauderdale ARVO meeting 2006. 

Yu, W.Z., et al. 2003. Gene transfer of kringle 5 of plasminogen by electroporation inhibits corneal neovascularization. Ophthalmic Res 35 239. 

Figure 23-10 Rosacea with severe blepharitis. Note the thickened lid margins and the corneal neovascularization. This is the same patient as seen in Figure 23-9. (From Palay DA, Krachmer JH. Conjunctival abnormalities. In Primary care ophthalmology, ed. 2. Philadelphia Mosby, 2005 98.)...

Figure 25-26 Corneal neovascularization in a patient with atopic keratoconjunctivitis. (Courtesy William Wallace, O.D.)...

Figure 26-54 (A-C) Corneal neovascularization secondary to contact lens wear. (Photos A and B courtesy of Pat Caroline photo C courtesy of Dr. Tammy Than.)...

A number of other OADRs are associated with this drug but are listed as imlikely (corneal neovascularization, activation of herpes simplex) or unclassifiable (cataracts, decreased accommodation, iritis). 

Unlikely Umbal infiltrates, corneal neovascularization, keratoconus, activation of herpes simplex, exophthalmos, pupil abnormalities, vitreous disturbance, glaucoma. 

Li WW, Casey R, Gonzalez EM, Folkman J. Angiostatic steroids potentiated by sulfated cyclodextrins inhibit corneal neovascularization. Invest Ophthalmol Vis Sci 1991 32 2898-2905. 

BenEzra D, Griffin BW, Maftzir G, et al. Topical formulations of novel angiostatic steroids inhibit rabbit corneal neovascularization. Invest Ophthalmol Vis Sci 1997 ... 

Proia AD, Hirakata A, Mclnnes JS, et al. The effect of angiostatic steroids and b-cyclo-dextrin tetradecasulfate on corneal neovascularization in the rat. Exp Eye Res 1993 57 693-698. 

Lai CM, Spilsbury K, Brankov M, Zaknich T, Rakoczy PE. Inhibition of corneal neovascularization by recombinant adenovirus mediated antisense VEGF RNA. Exp Eye Res 2002 75 625-634. 

Antigen-rechallenged eyes treated with sustained-release dexamethasone also had less inflammation than control eyes and late complications including corneal neovascularization, cataract, and hypotony were less prevalent in treated eyes. A separate toxicity study also demonstrated that sustained-release dexamethasone was safe using clinical, electrophysiological, and histological parameters (12). 

Mwaikambo, B.R. et al. Activation of CD36 inhibits and induces regression of inflammatory corneal neovascularization. Invest Ophthalmol. Vis. Sci. 47 (2006) 4356-64. 

Ophthalmology ocular neovascularizations - age related macular degeneration - corneal neovascularization... 

U. Schmidt-Erfurth, T. Hasan, K. Schomacker, T. Flotte, R. Birngruber (1995). In vivo uptake of liposomal benzoporphyrin derivative and photothrombosis in experimental corneal neovascularization. Lasers Surg. Med., 17, 178-188. 

Fig. 1. Rat cornea neovascularization in response to MIG (ELR CXC chemokine), IL-8 (ELR CXC chemokine), bFGF, and VEGF, or combinations of these cytokines with MIG. Panels A, B, C, E, and G, represent the corneal neovascular response to a hydron pellet containing vehicle control, MIG (10 nAf), IL-8 (10 nM), bFGF (10 nM), or VEGF (10 nAf), respectively. Panels D, F, and H represent the corneal neovascular response to a hydron pellet containing IL-8+MIG, bFGF+MIG, VEGF+MIG, respectively. All panels are at 25X magnification.

Observational studies Topical bevacizumab (5 mg/ml five times a day for 0.5-12 months) was used in 27 patients (30 eyes) with corneal neovascularization due to several causes and not responding to conventional therapy [1 ]. In five patients (five eyes) new epithelial defects developed (which could have been due to the underlying disease). There were no drug-related ocular or systemic adverse events or allergic reactions. 

Observational studies The short-term and long-term safety of topical bevacizumab 5 mg/ml for progressive corneal neovascularization secondary to a variety of corneal diseases and not responding to conventional anti-inflammatory treatment have been evaluated in 30 eyes of 27 patients Five patients (five eyes) developed new corneal epithelial defects. The authors warned against using bevacizumab in patients with epithelial defects and neurotrophic keratopathy. There were no allergic reactions, ocular drug-related complaints, or systemic adverse reactions. 

Koenig Y, Bock F, Horn F, Kruse F, Straub K, Cursiefen C. Short-and long-term safety profile and efficacy of topical beva-cizumah eye drops against corneal neovascularization. Graefes Arch Clin Exp Ophthalmol 2009 247 1375-82. 

The big diameter LK was first introduced in the year 2000 by Vajpayee [50] for a use in the surgical treatment of sequelae due to corneal burns. Vajpayee has recorded the results of nine ocular operations. The intervention begins with a conjunctival peritectomy over 360°. The conjunctiva is reclined backwards. The recipient cornea is trepanned to a 12-13 mm diameter and to a 300 pm depth. The lamellar graft is sampled via a trepanation at 1.5 mm back to the limbus in order to include LSC. It is then sutured by 24 10/0 nylon stitches. Despite the limbus allograft, no immunosuppressive therapy has been prescribed. The operation was practiced about 30 months after the occurrence of the burn. Results are recorded after a 7.4 month observation. The visual acuity has improved in six cases. No recurrence of the corneal neovascularization and no... 

---